One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.
In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...
Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...
News-Medical.Net on MSN
Study finds high intake of ultra-processed foods tied to reduced DNA methylation
Women who consumed more ultra-processed foods (UPFs) showed distinct DNA methylation patterns, mostly reduced across key gene ...
Please provide your email address to receive an email when new articles are posted on . The Nobel Assembly at Karolinska Institutet in Sweden announced the honor today. Victor R. Ambros, PhD, and Gary ...
We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...
Vinay Prasad, chief of the FDA’s Center for Biologics Evaluation and Research, is planning to publish a paper this month to ...
STOCKHOLM (AP) — Two scientists won the Nobel Prize in physiology or medicine on Monday for their discovery of microRNA, tiny pieces of genetic material that alter how genes work at the cellular level ...
The 2024 Nobel Prize in physiology or medicine has been awarded to US scientists Victor Ambros and Gary Ruvkun for their work on the discovery of microRNA, a molecule that governs how cells in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback